CHANGES OF INFLAMMATORY MARKERS ARE INDEPENDENT OF BLOOD PRESSURE- AND LIPID-LOWERING EFFECTS OF ANGIOTENSIN II RECEPTOR BLOCKER AND STATIN COMBINATION THERAPY ArticleVillevalde S., Kotovskaya Y., Kobalava Z., Mirilashvili T.Journal of Hypertension. Vol. 26. 2008.
CELL CULTURE AS A TESTING SYSTEM FOR LIPID-LOWERING SUBSTANCES ArticleJargin S.V.Virchows Archiv-European Journal of Pathology. Vol. 452. 2008.